Company record
Omeros Corporation develops biopharmaceutical therapeutics, offering a portfolio of protein‑based drugs designed for central nervous system disorders, inflammatory conditions, oncology, and coagulopathy treatments. The company supplies its products to both scientific research and pharmaceutical markets.
This directory record does not yet have a linked material-flow brief.